PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress Chord Energy CHRD Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency Gains PLBY Q1 2026 Earnings Significant EPS Miss Amidst Strategic Transformation MRNA Q1 2026 Earnings NarrowerThanExpected Loss Despite Revenue Absence SWKHL Q3 2025 Earnings Strong EPS Beat Driven by Portfolio Performance LBRDK Q3 2025 Earnings Strong EPS Beat Fueled by Investment Gains Stock Edges Lower